Related references
Note: Only part of the references are listed.Little to lose and no other options: Ethical issues in efforts to facilitate expanded access to investigational drugs
Eline M. Bunnik et al.
HEALTH POLICY (2018)
Patient-Driven Second Opinions in Oncology: A Systematic Review
Marij A. Hillen et al.
ONCOLOGIST (2017)
Questioning patient engagement: research scientists' perceptions of the challenges of patient engagement in a cardiovascular research network
Sandra L. Carroll et al.
PATIENT PREFERENCE AND ADHERENCE (2017)
Recommendations to Facilitate Expanded Access to Investigational Therapies for Seriously Ill Patients
Rebecca N. Jerome et al.
ACADEMIC MEDICINE (2016)
(R)evolution: toward a new paradigm of policy and patient advocacy for expanded access to experimental treatments
Melissa Hogan
BMC MEDICINE (2016)
Going social to access experimental and potentially life-saving treatment: an assessment of the policy and online patient advocacy environment for expanded access
Tim K. Mackey et al.
BMC MEDICINE (2016)
Can the referring surgeon enhance accrual of breast cancer patients to medical and radiation oncology trials? The ENHANCE study
A. Arnaout et al.
CURRENT ONCOLOGY (2016)
Right-to-try laws and individual patient compassionate use of experimental oncology medications: A call for improved provider-patient communication
Michael Hoerger
DEATH STUDIES (2016)
Right-to-Try Laws: Hope, Hype, and Unintended Consequences
Alison Bateman-House et al.
ANNALS OF INTERNAL MEDICINE (2015)
Access to Investigational Drugs: FDA Expanded Access Programs or Right-to-Try Legislation?
M. E. Blair Holbein et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2015)
Health literacy in Europe: comparative results of the European health literacy survey (HLS-EU)
Kristine Sorensen et al.
EUROPEAN JOURNAL OF PUBLIC HEALTH (2015)
Should patients in need be given access to experimental drugs?
Arthur L. Caplan et al.
EXPERT OPINION ON PHARMACOTHERAPY (2015)
Practical, Legal, and Ethical Issues in Expanded Access to Investigational Drugs
Jonathan J. Darrow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Is the role as gatekeeper still feasible? A survey among Dutch general practitioners
Joost Johan Godert Wammes et al.
FAMILY PRACTICE (2014)
Evaluation of Patient Enrollment in Oncology Phase I Clinical Trials
Diane A. J. van der Biessen et al.
ONCOLOGIST (2013)
I Had Already Made Up My Mind Patients and Caregivers' Perspectives on Making the Decision to Participate in Research at a US Cancer Referral Center
Kathleen Shannon-Dorcy et al.
CANCER NURSING (2011)
Qualitative description - the poor cousin of health research?
Mette Asbjoern Neergaard et al.
BMC MEDICAL RESEARCH METHODOLOGY (2009)
Right to Experimental Treatment: FDA New Drug Approval, Constitutional Rights, and the Public's Health
Elizabeth Weeks Leonard
JOURNAL OF LAW MEDICINE & ETHICS (2009)
Access to Experimental Drugs for Terminally Ill Patients
Benjamin P. Falit et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Understanding the attitudes of the elderly towards enrolment into cancer clinical trials
CA Townsley et al.
BMC CANCER (2006)
Share Paper
